Omeros Stock (NASDAQ: OMER) stock price, news, charts, stock research, profile.
Open | $5.36 |
Close | $5.22 |
Volume / Avg. | 244.54K / 337.21K |
Day Range | 5.09 - 5.41 |
52 Wk Range | 0.92 - 5.68 |
Market Cap | $316.38M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | 23.26% |
Days to Cover | 54.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Omeros (NASDAQ:OMER) through any online brokerage.
Other companies in Omeros’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and Xeris Biopharma Holdings (NASDAQ:XERS).
There is no analysis for Omeros.
Omeros has a consensus price target of $5.25.
The stock price for Omeros (NASDAQ: OMER) is $5.46 last updated July 26, 2024 at 7:35 PM EDT.
There are no upcoming dividends for Omeros.
Omeros’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Omeros.
Omeros is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.